directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2
Published June 24, 2026 · Recall initiated: April 30, 2026
Summary
FDA records medical device Class II recall Z-2460-2026, published June 24, 2026 and initiated April 30, 2026. Recalling firm: Accriva Diagnostics, Inc.; Status: Ongoing; Reported quantity: 6060; Lot: Lot #: A6DLA001 Unique Device Identifier: 10711234170373. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Assayed Whole blood control contains labeling with incorrect performance range.
What to do
Voluntary: Firm initiated
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Accriva Diagnostics, Inc.
- Distributor
- Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, FL, GA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MT, NC, NJ, NM, NY, OH, OK, PA, SC, TN, TX, VA, VT, WA, WI, WV and the countries of Canada, Hong Kong, Spain.
- Lot
- Lot #: A6DLA001 Unique Device Identifier: 10711234170373
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAHemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette,November 11, 2026
- FDARitmed Neurological Sponges, 0.75x0.75in, Sterile, REF: 85995CJune 24, 2026
- FDATRI TS BASEPLATE SIZE 3. Part Number: 5521-B-300.June 24, 2026
- FDARitmed Neurological Sponges, Description/REF: 0.5x0.5in, Non-Sterile/55992C; 0.5x1.0in, Non-Sterile/55993C;June 24, 2026
- FDATRI TS BASEPLATE SIZE 4. Part Number: 5521-B-400.June 24, 2026
- FDAAVOXimeter 1000E, Product Number: AVOX1000E. The AVOXimeter 1000E is a battery-operated bedside whole bloodNovember 6, 2024
Questions about this recall
Was directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2 recalled?
Yes. FDA published recall Z-2460-2026 on June 24, 2026. Reported hazard: Assayed Whole blood control contains labeling with incorrect performance range.
What should I do if I have this product?
Voluntary: Firm initiated